Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incidence of Immediate Onset Systemic Allergic Reactions in Patients Treated With Plenaxis®

NCT00103623 is registered in ClinicalTrials.gov with PRAECIS Pharmaceuticals Inc. as lead sponsor.

NCT NCT00103623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00103623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incidence of Immediate Onset Systemic Allergic Reactions in Patients Treated With Plenaxis®
Lead sponsor
PRAECIS Pharmaceuticals Inc.
Phase
Phase 4
Overall status
Suspended
Start date
June 30, 2004
Completion date
December 31, 2008
Enrollment
2,000
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer